Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exacerbations and Their Outcomes International (EXACOS International): Understanding Burden of Severe Exacerbations of COPD and Association Between Frequency of Severe Exacerbations Clinical and Health-care Utilization Outcomes in Less Well-resourced Countries

NCT04928417 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT04928417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04928417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exacerbations and Their Outcomes International (EXACOS International): Understanding Burden of Severe Exacerbations of COPD and Association Between Frequency of Severe Exacerbations Clinical and Health-care Utilization Outcomes in Less Well-resourced Countries
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 26, 2021
Completion date
November 30, 2022
Enrollment
1,762 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease